Searchable abstracts of presentations at key conferences on calcified tissues

ba0002p108 | (1) | ICCBH2013

Antenatal glucocorticoid injections do not aggravate stress-induced bone loss in young adult mice

Henneicke Holger , Gasparini Sylvia J , Brennan-Speranza Tara C , Zhou Hong , Seibel Markus J

Antenatal glucocorticoid (GC) injections are not only used to enhance fetal lung maturation in preterm children but also for the treatment of maternal conditions such as autoimmune diseases or infections. Animal models and clinical studies suggest that the regulation of the hypothalamic–pituitary–adrenal axis is altered in the offspring of GC-treated mothers with increased sensitivity to stress.Objective: The aim of this study is i) to define t...

ba0003pp414 | Steroid hormones and receptors | ECTS2014

Glucocorticoids suppress inflammation in arthritis via the glucocorticoid receptor in non-hematopoietic cells

Baschant Ulrike , Culemann Stephan , Koenen Mascha , Zhou Hong , Seibel Markus , Hofbauer Lorenz , Tuckermann Jan

Owing to their anti-inflammatory effects, steroid therapy using glucocorticoids (GCs) is still part of the treatment of rheumatoid arthritis (RA), despite several severe side effects like glucocorticoid-induced osteoporosis (GIO). Until now the molecular mechanisms underlying the beneficial and side effects of GC therapy are poorly understood. GCs exert their actions via the glucocorticoid receptor (GR) that alters gene expression by either binding as a dimer to GC response el...

ba0005ni7 | Abstract Presentations | ECTS2016

Exposure to chronic stress induces bone loss via glucocorticoid signalling in osteoblasts

Henneicke Holger , Li Jing-Bao , Gasparini Sylvia J , Seibel Markus J , Zhou Hong

Chronic stress and depression are associated with alterations in the hypothalamic–pituitary–adrenal signalling cascade and considered a risk factor for bone loss and fractures. However, the mechanisms underlying the association between stress and poor bone health are unclear. Utilising a transgenic (tg) mouse model in which glucocorticoid signalling is selectively disrupted in mature osteoblasts and osteocytes (HSD2OB-tg mice), the current study examines t...

ba0005p491 | Steroid hormones and receptors | ECTS2016

Exposure to chronic stress induces bone loss via glucocorticoid signalling in osteoblasts

Henneicke Holger , Li Jing-Bao , Gasparini Sylvia J , Seibel Markus J , Zhou Hong

Chronic stress and depression are associated with alterations in the hypothalamic-pituitary-adrenal signalling cascade and considered a risk factor for bone loss and fractures. However, the mechanisms underlying the association between stress and poor bone health are unclear. Utilising a transgenic (tg) mouse model in which glucocorticoid signalling is selectively disrupted in mature osteoblasts and osteocytes (HSD2OB-tg mice), the current study examines the impact ...

ba0003pp416 | Steroid hormones and receptors | ECTS2014

Novel mechanisms of action and new target genes of the glucocorticoid receptor in inflammatory bone disease and bone loss

Baschant Ulrike , Ahmad Mubashir , Koenen Mascha , Knoll Jeanette , Culemann Stephan , Schauer Sebastian , Bauer Kerstin , Wittig-Blaich Stephanie , Rauch Alexander , Kronke Gehrhard , Dudeck Anne , David Jean-Pierre , Rauner Martina , Seibel Markus , Ploubidou Aspasia , Zhou Hong , Hofbauer Lorenz , Tuckermann Jan

Glucocorticoids (GCs) are widely used to treat chronic inflammatory diseases such as rheumatoid (RA) and lead to multiple side effects including glucocorticoid induced osteoporosis (GIO). Our work challenges the dogma that transrepression of pro-inflammatory genes by the glucocorticoid receptor (GR) is solely responsible for reducing inflammation, whereas transactivation of genes is causing side effects.Using conditional and function selective mutant mic...